Butterfly Network, Inc. (BFLY) vs Haemonetics Corporation (HAE)
Butterfly Network, Inc. and Haemonetics Corporation are both Medical Devices companies. Haemonetics Corporation is the larger, with a market value of $4.8B against $2.6B — 1.9× the size. Butterfly Network, Inc. has negative trailing earnings, so its P/E is not meaningful; Haemonetics Corporation trades at 51.4×. Butterfly Network, Inc. grew revenue faster over the last twelve months: 28.1% against 0.44%. Haemonetics Corporation has the higher net margin (7.12% vs −66.7%) and the higher return on invested capital (5.62% vs −76.6%). Across the 19 metrics below, Haemonetics Corporation leads on 13 and Butterfly Network, Inc. on 6.
Valuation
Profitability
| Metric | BFLY | HAE | Medical Devices median |
|---|---|---|---|
| Gross margin | 52.64% | 59.03% | 56.01% |
| Operating margin | (70.79%) | 11.86% | (15.03%) |
| Net margin | (66.74%) | 7.12% | (20.40%) |
| Free cash flow margin | (25.01%) | 21.64% | (7.24%) |
| Return on equity | (35.46%) | 11.20% | (15.32%) |
| Return on assets | (25.11%) | 3.99% | (19.72%) |
| Return on invested capital | (76.64%) | 5.62% | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack